Abstract Glucagon-like peptide-1 (GLP-1) is an incretin hormone shown to be active in the treatment of type-2 diabetes (T2D) and has also been shown as efficacious in Alzheimer’s disease (AD). Dipeptidyl peptidase-4 (DPP-4), an enzyme that is expressed in numerous cells, rapidly inactivates endogenous GLP-1. Therefore, DPP-4 inhibition is employed as a therapeutic avenue to increase GLP-1 levels in the management of T2D. The effectiveness of DPP-4 inhibitors in the treatment of AD has been reported in various animal models of AD. With this background, the present study was designed to examine the effectiveness of linagliptin, a DPP-4 inhibitor in the 3xTg-AD mouse model of Alzheimer’s disease. Nine-month-old 3xTg-AD mice were administered linagliptin orally (5, 10, and 20 mg/kg) for 8 weeks. At the end of the linagliptin treatment, mice were evaluated for cognitive ability on the Morris Water Maze and Y-maze. Following cognitive evaluation, mice were sacrificed to determine the effect of the linagliptin on brain incretin levels, amyloid burden, tau phosphorylation, and neuroinflammation. We confirm that linagliptin treatment for 8 weeks mitigates the cognitive deficits present in 3xTg-AD mice. Moreover, linagliptin also improves brain incretin levels and attenuates amyloid beta, tau phosphorylation as well as neuroinflammation. In conclusion, linagliptin possesses neuroprotective properties that may be attributed to the improvement of incretin levels in the brain.
mice                0.9961564268981431^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Mouse                 

linagliptin                   0.9999999999970441^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Linagliptin           

avenue                        0.7848469308368333^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Road                  

endogenous                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Endogeny              

mice                          0.9961564268981431^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Mouse                 

cells                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cell_(biology)        

linagliptin                   0.9999999999970441^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Linagliptin           

AD                            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Alzheimer's_disease   

type-2 diabetes               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Diabetes_mellitus_type_2

hormone                       0.9999999999745341^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Hormone               

incretin                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Incretin              

GLP-1                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Glucagon-like_peptide-1

tau                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Tau_protein           

enzyme                        0.9988444472462696^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Enzyme_inhibitor      

incretin                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Incretin              

DPP-4                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Dipeptidyl_peptidase-4

mice                          0.9961564268981431^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Mouse                 

GLP-1                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Glucagon-like_peptide-1

attenuates                    0.9999994697916732^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Attenuation           

tau                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Tau_protein           

linagliptin                   0.9999999999970441^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Linagliptin           

AD                            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Alzheimer's_disease   

GLP-1                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Glucagon-like_peptide-1

neuroprotective               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Neuroprotection       

incretin                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Incretin              

linagliptin                   0.9999999999970441^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Linagliptin           

brain                         0.9999937419397887^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Brain                 

disease                       0.9788360360924271^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Disease               

mice                          0.9961564268981431^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Mouse                 

incretin                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Incretin              

disease                       0.9788360360924271^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Disease               

cognitive                     0.5878400734865766^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cognitive_deficit     

brain                         0.9999937419397887^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Brain                 

cognitive deficits            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cognitive_deficit     

neuroinflammation             1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Inflammation          

cognitive ability             0.9999999999398597^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cognition             

amyloid                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Beta_amyloid          

DPP-4                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Dipeptidyl_peptidase-4

animal models                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Animal_model          

Glucagon-like peptide-1       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Glucagon-like_peptide-1

Morris Water Maze             1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Morris_water_navigation_task

AD                            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Alzheimer's_disease   

linagliptin                   0.9999999999970441^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Linagliptin           

brain                         0.9999937419397887^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Brain                 

DPP-4 inhibitors              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Dipeptidyl_peptidase-4_inhibitor

inhibitor                     0.9999999999971578^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Enzyme_inhibitor      

Dipeptidyl peptidase-4        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Dipeptidyl_peptidase-4

neuroinflammation             1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Inflammation          

linagliptin                   0.9999999999970441^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Linagliptin           

phosphorylation               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Phosphorylation       

mouse model                   0.9999999999855618^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Animal_model          

DPP-4                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Dipeptidyl_peptidase-4

linagliptin                   0.9999999999970441^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Linagliptin           

phosphorylation               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Phosphorylation       

amyloid beta                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Beta_amyloid          

